Individuals in the denominator who received at least one pneumococcal vaccination after age 65 or within the last five years.
Diabetic patients aged 65–74
Patients of all ages with chronic diseases, including those with diabetes, are more susceptible to pneumococcal infections compared to healthy individuals. Diabetic patients are at increased risk for morbidity and mortality from bacteremia (blood infection) caused by the pneumococcus bacterium (1). According to the Ministry of Health recommendations, adult diabetic patients should receive a single dose of the pneumococcal polysaccharide vaccine (covering 23 strains of the bacterium, PPV23) (2). For patients over 65 who received one or more doses of the polysaccharide vaccine before age 65, it is recommended to administer one additional dose after they turn 65, provided that at least five years have passed since their last dose.
Note: This measure refers to pneumococcal vaccinations given with the polysaccharide vaccine (covering 23 strains of the bacterium) among diabetic patients aged 65–74.
1. Centers for Disease Control and Prevention. Pneumonia Can Be Prevented—Vaccines Can Help | CDC [Internet]. [cited 2023 Feb 7]. Available from: https://www.cdc.gov/pneumonia/prevention.html
2. האגף לאפידמיולוגיה משרד הבריאות. תדריך חיסונים 1999. 2015.
